A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2011
10/20/2011	US20110256147 Diagnostic and treatment methods for cancer based on immune inhibitors
10/20/2011	US20110256142 Novel methods and antibodies for treating cancer
10/20/2011	US20110256139 Therapeutic Uses Of Monoclonal Antibodies To The Angiotensin-II Type 1 Receptor
10/20/2011	US20110256130 Methods of treating inflammatory disorders
10/20/2011	US20110256126 IL-17A/F Heterologous Polypeptides and Therapeutic Uses Thereof
10/20/2011	US20110256125 Materials and methods for improved immunoglycoproteins
10/20/2011	US20110256124 METHODS FOR IMPROVING THE BIOACTIVITY OF THERAPEUTIC IgE ANTIBODIES FOR THE TREATMENT OF DISEASE
10/20/2011	US20110256123 Methods and uses of leptin in immune modulation and hepatocellular carcinoma
10/20/2011	US20110256121 Methods and kits for diagnosing or monitoring autoimmune and chronic inflammatory diseases
10/20/2011	US20110256117 Manufacturing and use of composite scaffolds
10/20/2011	US20110256115 Hydrosoluble [6)o-alpha-d-glcp-(1->]n-6-o-beta-d-glcp-(1->-phenolic derivatives with dermocosmetic, nutritional and therapeutic applications, and compositions containing said water soluble compounds
10/20/2011	US20110256098 Immunotherapy for chronic hepatitis c virus infection
10/20/2011	US20110256094 Methods and Compositions for Chlamydial Antigens for Diagnosis and Treatment of Chlamydial Infection and Disease
10/20/2011	US20110256061 Binding agents to the Integrin Alpha-11 subunit, and uses thereof
10/20/2011	US20110256053 Multiple Signaling Pathways Induced by Hexavalent, Monospecific and Bispecific Antibodies for Enhanced Toxicity to B-Cell Lymphomas and Other Diseases
10/20/2011	CA2796248A1 Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of crohn's disease
10/20/2011	CA2795947A1 Method for treating solid tumors
10/20/2011	CA2795349A1 Targeted pyrrolobenzodiazepine conjugates
10/20/2011	CA2795078A1 Proteins that bind pi16 and uses thereof
10/20/2011	CA2792278A1 2,4-pyrimidinediamine compounds and prodrugs thereof and their uses
10/19/2011	EP2377883A1 Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease
10/19/2011	EP2377875A1 Antioxidant
10/19/2011	EP2377851A1 Isoquinoline derivative
10/19/2011	EP2377548A2 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
10/19/2011	EP2376502A1 Thiazolopyridine sirtuin modulating compounds
10/19/2011	EP2376490A1 Imidazopyridine compounds
10/19/2011	EP2376484A1 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
10/19/2011	EP2376126A2 Antagonists of il-6 to prevent or treat thrombosis
10/19/2011	EP2376115A1 Methods and systems for inducing immunologic tolerance to non-self antigens
10/19/2011	EP2376108A2 IgE CH3 PEPTIDE VACCINE
10/19/2011	EP2376079A1 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids
10/19/2011	EP2376069A2 Microparticles comprising adipose stem cells
10/19/2011	EP2375897A1 Methods and compositions containing mtor inhibitors for enhancing immune responses
10/19/2011	EP2221377B1 Oligonucleotide compositions with enhanced efficiency
10/19/2011	EP1967195B1 Antacid
10/19/2011	EP1924159B1 A composition comprising an extract of Tiarella polyphylla having antiasthmatic activity
10/19/2011	EP1891075B1 Tricyclic spiro derivatives as crth2 modulators
10/19/2011	EP1494671B1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists
10/19/2011	EP1405560B1 Il-18 transgenic animal
10/19/2011	EP1372735B1 Conjugate of hydroxyalkyl starch and an active agent
10/19/2011	EP1165132B1 Dry formulation for transcutaneous immunization
10/19/2011	EP1041982B1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/19/2011	CN202011849U Equipment for extracting and concentrating polysaccharide from medicinal materials
10/19/2011	CN1706385B New composition for treating seasonal and perennial allergic rhinitis
10/19/2011	CN102224242A Novel gene cluster
10/19/2011	CN102223894A Hiv/siv vaccines for the generation of mucosal and systemic immunity
10/19/2011	CN102220283A Multifunctional immune killing transgenic cell as well as preparation method and use thereof
10/19/2011	CN102220256A Yeast expression system for expressing HAS-Vmip-II fusion protein and construction method thereof
10/19/2011	CN102220216A Acanthopanax sessiliflorus white spirit and brewing method thereof
10/19/2011	CN102219720A Novel selenic acid biological material with anti-aging function
10/19/2011	CN102218144A Method for regulating content of micro-ribonucleic acids in organism and use thereof
10/19/2011	CN102218135A Application of alpha2-3 neuraminidase in induction of transplantation immune tolerance
10/19/2011	CN102218101A Medicine manufacturing technology and preparation method of Taisui capable of clearing kidney poison and raising vitality
10/19/2011	CN102218084A Traditional Chinese medicament health preserving preparation having effects of enhancing immunity, resisting ageing and improving sub-health
10/19/2011	CN102218082A Method for extracting and purifying natural-state yellow bee propolis
10/19/2011	CN102218075A Composition for down-regulating pro-inflammatory markers
10/19/2011	CN102218071A Micronized deflazacort oral preparation and preparation method thereof
10/19/2011	CN102218070A Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone
10/19/2011	CN102218058A Application of sparstolenin B as TLR2 (Toll-like receptor 2)/TLR4 (Toll-like receptor 4) antagonist in pharmacy
10/19/2011	CN102218056A Use of butenolide I in preparing drugs for controlling immunological liver injury
10/19/2011	CN102218041A Ebastine solid dispersion and high-dissolubility ebastine tablet prepared by the same
10/19/2011	CN102217757A Plant superoxide dismutase buccal tablets and preparation method thereof
10/19/2011	CN101904819B Method for preparing taurine particles
10/19/2011	CN101696205B 3-(substituted xylylenimine-2-yl)-2,6-dioxopiperidine polymorph and pharmaceutical composition
10/19/2011	CN101555291B Extraction and separation technology of ginseng polysaccharides
10/19/2011	CN101304995B Thiazole derivatives and use thereof
10/19/2011	CN101095671B Iguratimod oral double-layer sustained-release preparation
10/18/2011	US8039488 Methods and compositions for inhibition of angiogenesis
10/18/2011	US8039257 Pre-transplant accomodated organs resistant to anti-donor immunity
10/18/2011	CA2579207C Morpholine compound
10/18/2011	CA2478813C Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/18/2011	CA2475312C N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
10/18/2011	CA2470643C Cleavable reagents for specific delivery to disease sites
10/18/2011	CA2465156C Il-21 antagonists
10/18/2011	CA2446189C Peptides and related molecules that bind to tall-1
10/18/2011	CA2398018C Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/18/2011	CA2391843C Hcv vaccine compositions
10/18/2011	CA2360275C Novel stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas
10/18/2011	CA2311492C Vaccines with an ltb adjuvant
10/18/2011	CA2221682C Method of preparing a monoclonal antibody, monoclonal antibody, a pharmaceutical composition and a diagnostic reagent
10/13/2011	WO2011127070A2 IRE-1α INHIBITORS
10/13/2011	WO2011126882A2 Therapeutic peptides and their derivatives and therapeutic uses thereof
10/13/2011	WO2011126264A2 Method for increasing activity in human stem cell
10/13/2011	WO2011125600A1 Method and device for cell activation
10/13/2011	WO2011125029A1 THERAPEUTIC USE OF THE ß2m PROTEIN
10/13/2011	WO2011124668A1 Plasma-derived immunoglobulin for use in the treatment and prevention of immune reconstitution inflammatory syndrome (iris)
10/13/2011	US20110251283 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
10/13/2011	US20110251238 Ppar agonist compositions and methods of use
10/13/2011	US20110251232 Modified release compositions comprising tacrolimus
10/13/2011	US20110251231 Modified release compositions comprising tacrolimus
10/13/2011	US20110251226 Cyclohexylamin isoquinolone derivatives
10/13/2011	US20110251217 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
10/13/2011	US20110251215 Macrocyclic compounds and their use as kinase inhibitors
10/13/2011	US20110251192 Amide compounds, their pharmaceutical compositions, their preparation method and their uses
10/13/2011	US20110251180 Pharmaceutical agent comprising quinolone compound
10/13/2011	US20110251179 3,4-DIHYDRO-2H-PYRROLO[1,2-a]PYRAZIN-1-ONE DERIVATIVES
10/13/2011	US20110251177 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
10/13/2011	US20110251170 New polymorphic form of 1-(4--2-ethyl-benzyl)-azetidine-3-carboxylic
10/13/2011	US20110250301 Water insoluble helychrisum extract, process for preparing the same and uses thereof
10/13/2011	US20110250287 One step removal of selected molecules from body fluid and tissue

1 ... 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 ... 1172